A 32-year-old woman with obesity presents with exertional dyspnea and wheezing. She uses her short-acting beta-agonist inhaler three times per week during the day and once monthly at night. Spirometry shows FEV1 85 percent predicted with reversible obstruction. What is the preferred initial controller therapy?